These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 11836595)
1. Overexpression of p53 protein and point mutation of K-ras genes in primary carcinoma of the small intestine. Nishiyama K; Yao T; Yonemasu H; Yamaguchi K; Tanaka M; Tsuneyoshi M Oncol Rep; 2002; 9(2):293-300. PubMed ID: 11836595 [TBL] [Abstract][Full Text] [Related]
2. p53 and p21/Waf1 protein expression and K-ras codon 12 mutation in carcinoma of the papilla of Vater. Zhao B; Kimura W; Futakawa N; Muto T; Kubota K; Harihara Y; Takayama T; Makuuchi M Am J Gastroenterol; 1999 Aug; 94(8):2128-34. PubMed ID: 10445539 [TBL] [Abstract][Full Text] [Related]
3. [Findings of genetic changes in small intestinal carcinomas]. Hirai A; Hibi K; Nakamura H; Fujikake Y; Matsui T; Kasai Y; Akiyama S; Ito K; Takagi H Gan To Kagaku Ryoho; 1997 Jul; 24 Suppl 2():332-6. PubMed ID: 9263525 [TBL] [Abstract][Full Text] [Related]
4. [Molecular changes in adenocarcinoma of the small intestine associated with Peutz-Jeghers syndrome]. Hidalgo L; Villanueva A; Soler T; Matías Guiu X; Capellá G Rev Esp Enferm Dig; 1996 Feb; 88(2):137-40. PubMed ID: 8664070 [TBL] [Abstract][Full Text] [Related]
5. Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation. Wang Y; Yamaguchi Y; Watanabe H; Ohtsubo K; Wakabayashi T; Sawabu N J Gastroenterol; 2002; 37(10):831-9. PubMed ID: 12424567 [TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours. Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258 [TBL] [Abstract][Full Text] [Related]
7. The presence of K-12 ras mutations in duodenal adenocarcinomas and the absence of ras mutations in other small bowel adenocarcinomas and carcinoid tumors. Younes N; Fulton N; Tanaka R; Wayne J; Straus FH; Kaplan EL Cancer; 1997 May; 79(9):1804-8. PubMed ID: 9128999 [TBL] [Abstract][Full Text] [Related]
8. [Detection of K-ras oncogene activation in human lung cancer and its possible clinical application]. Zhang G; Sun Y; Wang M Zhonghua Jie He He Hu Xi Za Zhi; 1995 Oct; 18(5):282-4, 317. PubMed ID: 8762479 [TBL] [Abstract][Full Text] [Related]
9. [K-ras gene mutation in gallbladder carcinoma]. Roa JC; Roa I; de Aretxabala X; Melo A; Faría G; Tapia O Rev Med Chil; 2004 Aug; 132(8):955-60. PubMed ID: 15478297 [TBL] [Abstract][Full Text] [Related]
10. Topoisomerase IIalpha gene expression is regulated by the p53 tumor suppressor gene in nonsmall cell lung carcinoma patients. Liu D; Huang CL; Kameyama K; Hayashi E; Yamauchi A; Sumitomo S; Yokomise H Cancer; 2002 Apr; 94(8):2239-47. PubMed ID: 12001123 [TBL] [Abstract][Full Text] [Related]
11. p53 and K-ras status in duodenal adenomas in familial adenomatous polyposis. Kashiwagi H; Spigelman AD; Talbot IC; Debinski HS; McKie AB; Lemoine NR; Phillips RK Br J Surg; 1997 Jun; 84(6):826-9. PubMed ID: 9189100 [TBL] [Abstract][Full Text] [Related]
12. The frequency of p53, K-ras mutations, and microsatellite instability differs in uterine endometrioid and serous carcinoma: evidence of distinct molecular genetic pathways. Lax SF; Kendall B; Tashiro H; Slebos RJ; Hedrick L Cancer; 2000 Feb; 88(4):814-24. PubMed ID: 10679651 [TBL] [Abstract][Full Text] [Related]
13. c-k-ras and p53 mutations occur very early in adenocarcinoma of the lung. Li ZH; Zheng J; Weiss LM; Shibata D Am J Pathol; 1994 Feb; 144(2):303-9. PubMed ID: 8311114 [TBL] [Abstract][Full Text] [Related]
14. K-ras mutations in gastric stump carcinomas and in carcinomas from the non-operated stomach. van Rees BP; Musler A; Caspers E; Drillenburg P; Craanen ME; Polkowski W; Chibowski D; Offerhaus GJ Hepatogastroenterology; 1999; 46(27):2063-8. PubMed ID: 10430398 [TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions. Parwani AV; Geradts J; Caspers E; Offerhaus GJ; Yeo CJ; Cameron JL; Klimstra DS; Maitra A; Hruban RH; Argani P Mod Pathol; 2003 Apr; 16(4):299-308. PubMed ID: 12692194 [TBL] [Abstract][Full Text] [Related]
16. Low mutational rate of K-ras codon 12 in singular bronchoscopy specimens in suspected lung cancer. Spasova I; Novotna H; Vachtenheim J; Bartosova H; Patek J; Hoserova V; Zatloukal P; Kinkor Z Neoplasma; 2005; 52(3):255-9. PubMed ID: 15875089 [TBL] [Abstract][Full Text] [Related]
17. K-ras and p53 mutations and overexpressions as prognostic factors in female rectal carcinoma. Hirvikoski P; Auvinen A; Servomaa K; Kiuru A; Rytömaa T; Makkonen K; Kosma VM Anticancer Res; 1999; 19(1B):685-91. PubMed ID: 10216477 [TBL] [Abstract][Full Text] [Related]
18. p53 gene mutation and p53 protein overexpression in a patient with simultaneous double cancer of the gallbladder and bile duct associated with pancreaticobiliary maljunction. Kasuya K; Nagakawa Y; Matsudo T; Ozawa T; Tsuchida A; Aoki T; Itoi T; Itokawa F J Hepatobiliary Pancreat Surg; 2009; 16(3):376-81. PubMed ID: 19183832 [TBL] [Abstract][Full Text] [Related]